Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP473492.RAdDI_hcut1DxR4eMsI1HHANusdIUx-us6fWKhhQZMgfs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP473492.RAdDI_hcut1DxR4eMsI1HHANusdIUx-us6fWKhhQZMgfs130_assertion type Assertion NP473492.RAdDI_hcut1DxR4eMsI1HHANusdIUx-us6fWKhhQZMgfs130_head.
- NP473492.RAdDI_hcut1DxR4eMsI1HHANusdIUx-us6fWKhhQZMgfs130_assertion description "[The most common prostate cancer gene fusion, TMPRSS2-ERG, can be generated by the mechanism of interstitial deletion (Edel) about 39% to 60% of the time in clinically localized disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP473492.RAdDI_hcut1DxR4eMsI1HHANusdIUx-us6fWKhhQZMgfs130_provenance.
- NP473492.RAdDI_hcut1DxR4eMsI1HHANusdIUx-us6fWKhhQZMgfs130_assertion evidence source_evidence_literature NP473492.RAdDI_hcut1DxR4eMsI1HHANusdIUx-us6fWKhhQZMgfs130_provenance.
- NP473492.RAdDI_hcut1DxR4eMsI1HHANusdIUx-us6fWKhhQZMgfs130_assertion SIO_000772 18483239 NP473492.RAdDI_hcut1DxR4eMsI1HHANusdIUx-us6fWKhhQZMgfs130_provenance.
- NP473492.RAdDI_hcut1DxR4eMsI1HHANusdIUx-us6fWKhhQZMgfs130_assertion wasDerivedFrom befree-20140225 NP473492.RAdDI_hcut1DxR4eMsI1HHANusdIUx-us6fWKhhQZMgfs130_provenance.
- NP473492.RAdDI_hcut1DxR4eMsI1HHANusdIUx-us6fWKhhQZMgfs130_assertion wasGeneratedBy ECO_0000203 NP473492.RAdDI_hcut1DxR4eMsI1HHANusdIUx-us6fWKhhQZMgfs130_provenance.